September 27, 2022 Bioengineering Pretty cool! Nanoparticle-modified microrobots for in vivo antibiotic delivery to treat acute bacterial pneumonia (in mice).
September 12, 2022 Allergy/Immunology Tweaking CAR-T activity with on/off switches may reduce cytokine release syndrome.
August 4, 2022 Bioengineering Study succeeds at restoring selected molecular and cellular processes across multiple vital organs after death in pigs. Far from human use and a plethora of bioethical questions remain to be addressed.
June 15, 2022 Bioengineering Study in Nature outlines how in vitro and in vivo (mouse model), specific white blood cells (B-Cells) can be genetically programmed to produce anti-HIV antibodies thus offer a one-time treatment for the disease. Long way to go but elegant study design.
March 25, 2022 Bioengineering Early days but nonetheless intriguing; UBC scientists discover how to 3D print testicular cells
November 30, 2021 Bioengineering Kinematic-replicating xenobots constructed from frog embryonic cells. A fascinating window into how organizing cells in a specific configuration leads to a replicative behaviour not seen in cells or organisms.
August 19, 2021 Bioengineering Cancer patients’ own glioblastoma cells used in 3d bioprinting to develop living model to test efficacy of potential treatments prior to in vivo use. Still early days but very cool if succeeds and is adapted for clinical use. #GoScience
February 3, 2021 Bioengineering Excellent review of myths of enlisting more companies to make mRNA vaccine by @DerekLowe. Bespoke machines, processes & tech, multiple supply chains, a myriad of Sci & Eng expertise & steps needed before mass production. Many pharma companies can’t do it.
May 28, 2020 Allergy/Immunology The irony of claims of SARS-CoV-2 being a bacterium going viral. And, claims of antibody being a “cure” for Covid-19 are a tad premature when you have not done any animal or human trials to date. Good science but take the time to prove your claim.
